SR-BioPharma Building $32 Million Facility in China Medical City

Jiangsu SR-BioPharma Co. has broken ground on a new facility in Taizhou’s China Medical City, where it will make its vaccine for HPV. The facility will cost $32 million to build and be complete in one year. Operations will begin in September 2015. SR-BioPharma expects output from the facility will total $162 million. More details.... Share this with colleagues: // //